DIEM LINH TRAN: Open Payments
NPI 1639295892 · BALDWIN PARK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,153 in 11 payments from 9 companies in 2025. Trend: 2023 $1,939 · 2024 $1,625 · 2025 $1,153
Food & beverage: $1,153
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $374 |
| Regeneron Pharmaceuticals, Inc. | 1 | $150 |
| Apellis Pharmaceuticals, Inc. | 1 | $125 |
| Lilly USA, LLC | 1 | $125 |
| SANOFI-AVENTIS U.S. LLC | 1 | $122 |
| Sage Therapeutics, LLC | 1 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $67 |
| Sumitomo Pharma America, Inc. | 1 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
Products named: Auvelity, DUPIXENT, Syfovre, MOUNJARO, TZIELD, GEMTESA, CAPLYTA.
Industry payments across CA — which companies pay providers there.
